Towards the prevention of schizophrenia

被引:42
作者
Tsuang, MT
Stone, WS
Faraone, SV
机构
[1] Harvard Univ, Massachusetts Mental Hlth Ctr, Dept Psychiat, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Dept Psychiat, Brockton W Roxbury Vet Affairs Med Ctr, Boston, MA 02115 USA
[3] Massachusetts Gen Hosp, Psychiat Serv, Boston, MA 02114 USA
[4] Harvard Univ, Inst Psychiat Epidemiol & Genet, Boston, MA 02114 USA
[5] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA
关键词
schizotaxia; genetics; negative symptoms; neuropsychology; risperidone;
D O I
10.1016/S0006-3223(00)00934-3
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
There is a growing emphasis on attempts to identify the early signs and symptoms of schizophrenia, largely because early detection and treatment of psychosis (i.e., secondary prevention) are associated with relatively favorable clinical outcomes. This raises the issue of whether prevention of psychosis itself is possible. The achievement of this goal will require the identification of a premorbid state that could serve as the foundation for treatment strategies aimed ultimately at the prevention of schizophrenia. Fortunately evidence for such a state is emerging, in part because schizophrenia may result from a neurodevelopmental disorder that is associated with a variety of clinical, neurobiological, and neuropsychologic features occurring well before the onset of psychosis. These features may serve as both indicators of risk for subsequent deterioration and the foundation of treatment efforts. We reformulated Meehl's term schizotaxia to describe this liability and discuss here how its study could form the basis for future strategies of prevention. We also include a description of our initial attempts to devise treatment protocols for schizotaxia. II is concluded that schizotaxia is a feasible concept on which to base prevention efforts, anal that treatment of adult schizotaxia may be among the next steps in the process. (C) 2000 Society of Biological Psychiatry.
引用
收藏
页码:349 / 356
页数:8
相关论文
共 57 条
[1]  
Andreasen N, 1984, SCALE ASSESSMENT POS
[2]  
AUERBACH JG, 1993, ISRAEL J PSYCHIAT, V30, P40
[3]   Schizotypal disorder: At the crossroads of genetics and nosology [J].
Battaglia, M ;
Torgersen, S .
ACTA PSYCHIATRICA SCANDINAVICA, 1996, 94 (05) :303-310
[4]   Neonatal insult to the hippocampal region and schizophrenia: A review and a putative animal model [J].
Beauregard, M ;
Bachevalier, J .
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 1996, 41 (07) :446-456
[5]   NEUROLEPTICS - EFFECTS ON NEUROPSYCHOLOGICAL FUNCTION IN CHRONIC-SCHIZOPHRENIC PATIENTS [J].
CASSENS, G ;
INGLIS, AK ;
APPELBAUM, PS ;
GUTHEIL, TG .
SCHIZOPHRENIA BULLETIN, 1990, 16 (03) :477-499
[6]   ALLUSIVE THINKING IN PARENTS OF SCHIZOPHRENICS - METAANALYSIS [J].
CATTS, SV ;
MCCONAGHY, N ;
WARD, PB ;
FOX, AM ;
HADZIPAVLOVIC, D .
JOURNAL OF NERVOUS AND MENTAL DISEASE, 1993, 181 (05) :298-302
[7]   SOCIAL COMPETENCE DEFICITS IN ADOLESCENTS AT RISK FOR SCHIZOPHRENIA [J].
DWORKIN, RH ;
LEWIS, JA ;
CORNBLATT, BA ;
ERLENMEYERKIMLING, L .
JOURNAL OF NERVOUS AND MENTAL DISEASE, 1994, 182 (02) :103-108
[8]  
Erlenmeyer-Kimling L, 2000, AM J MED GENET, V97, P65, DOI 10.1002/(SICI)1096-8628(200021)97:1<65::AID-AJMG9>3.0.CO
[9]  
2-V
[10]  
ERLENMEYERKIMLI.L, 1982, SCHIZOPHRENIA BRAIN